Skin Diseases and Pregnancy: Which Heathcare Professionals ?

Skin Diseases: Which Heathcare Professionals do Pregnant Women in Vendee Use?

Pregnancy-induced physiological dermatological changes are common. In 2016, they represented between 23% (acne) and 75% (pigmentary changes) of pregnancies in France. Some dermatological changes require medical advice to identify a possible pathological rash.

These pathological rashes can be dangerous for the mother or the fetus.

The aim of this study is to assess the prevalence of skin diseases during pregnancy and to evaluate the care pathway in a healthcare sector (Vendee) for these pregnant women?

Study Overview

• Status: Completed
• Conditions: Pregnancy; Skin Abnormalities
• Intervention / Treatment: Other: questionnaire

Detailed Description

Pregnancy-induced physiological dermatological changes are common. In 2016, they represented between 23% (acne) and 75% (pigmentary changes) of pregnancies in France. Some dermatological changes require medical advice to identify a possible pathological rash.

These pathological rashes can be dangerous for the mother or the fetus. It is therefore essential to recognize them for a quick specialized treatment. They include: intrahepatic cholestasis of pregnancy, pemphigoid gestationis, polymorphic eruption during pregnancy, atopic eczema, generalized pustular psoriasis in pregnancy.

In view of the demography of dermatologists in the Vendee, 18 dermatologists in 2020 in all establishments (hospitals, clinics, practices), the general practitioner is at the center of these considerations.

The aim of this study is to assess the situation of skin disease during pregnancy and to evaluate the care pathway in a healthcare sector (Vendee) for these pregnant women?

• Study Type: Observational
• Enrollment (Actual): 317

Contacts and Locations

Study Locations

• France
  • La Roche sur Yon, France, 85000
    • CHD Vendée

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Prospective collection of data from a questionnaire answered by patients giving birth at the Departmental Hospital Center of Vendee during the postpartum period.

Description

Inclusion Criteria:

• Any woman who gives birth at Departmental Hospital Center of Vendee

Exclusion Criteria:

• Patient's refusal to participate in the study

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Identify the health care provider that pregnant women consult when experiencing a skin disease	Type of health care provider seeing a pregnant woman for skin disease	after delivery during the patient's stay in the maternity (2-3 days)

Collaborators and Investigators

• Sponsor: Centre Hospitalier Departemental Vendee
• Investigators: Principal Investigator: Guillaume DUCARME, Departmental Hospital Center of Vendee

Study record dates

Study Major Dates

• Study Start (Actual): April 7, 2021
• Primary Completion (Actual): April 7, 2021
• Study Completion (Actual): August 10, 2021

Study Registration Dates

• First Submitted: March 19, 2021
• First Submitted That Met QC Criteria: March 23, 2021
• First Posted (Actual): March 24, 2021

Study Record Updates

• Last Update Posted (Actual): September 9, 2021
• Last Update Submitted That Met QC Criteria: September 8, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Congenital Abnormalities; Skin Diseases; Skin Abnormalities
• Other Study ID Numbers: CHD21_0020

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No